(Q38570021)

4 September 2017

1 reference

title

Cisapride: a gastrointestinal prokinetic drug (English)

1 reference

4 September 2017

1 reference

J A Barone

1

1 reference

4 September 2017

L M Jessen

series ordinal

2

1 reference

4 September 2017

J L Colaizzi

series ordinal

3

1 reference

4 September 2017

R H Bierman

series ordinal

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

Annals of Pharmacotherapy

4 September 2017

1 reference

4 September 2017

28

1 reference

4 September 2017

488-500

1 reference

4 September 2017

4

1 reference

The enteric nervous system--an overview

4 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Neuroendocrine design of the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Enteric nervous system. I. Physiology and pathophysiology of the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Rational pharmacotherapy of gastrointestinal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Is the action of cisapride on the guinea-pig ileum mediated via 5-HT4 receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effects of cisapride on postcibal jejunal motor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Treatment approaches to reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Alkaline reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Healing and prevention of relapse of reflux oesophagitis by cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Treatment of chronic constipation with cisapride and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effect of cisapride on symptoms and biliary drainage in patients with postcholecystectomy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

No effect of cisapride on paracetamol absorption after oral simultaneous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

The action of cisapride on gastric emptying and the pharmacodynamics and pharmacokinetics of oral diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effect of single doses of cisapride and ranitidine administered simultaneously on plasma concentrations of cisapride and ranitidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Cisapride for gastro-oesophageal reflux and peptic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Histamine-2-receptor antagonists and gastric cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

Effect of cisapride on chronic idiopathic constipation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800413

10.1177/106002809402800413

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference